BOKIQSA
DEAD

Serial Number

90341741

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

Marilyn F. Kelly

Filing Date

Nov 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BOKIQSA Trademark

Serial Number: 90341741

BOKIQSA is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on November 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,799 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Trademark Details

Filing Date

November 25, 2020

Registration Date

Not Registered

Published for Opposition

November 9, 2021

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; monoclonal antibodies

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 7, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 7, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jun 18, 2024 EX5G
SOU EXTENSION 5 FILED
Jun 18, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 4, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jan 2, 2024 EX4G
SOU EXTENSION 4 FILED
Jan 2, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 2, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 2, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 2, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 2, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 30, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jun 28, 2023 EX3G
SOU EXTENSION 3 FILED
Jun 28, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 28, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 4, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 4, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 4, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 1, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jun 29, 2022 EX1G
SOU EXTENSION 1 FILED
Jun 29, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 29, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 4, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 1, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 23, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2021 NWOS
NEW APPLICATION ENTERED
Nov 28, 2020 NWAP